Vita Coco Company, Inc.
For the period ended Dec 31, 2025. Filed Feb 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 18, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Rule 10b5-1 Trading Plans
In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended December 31, 2025:
| Name | Title | Action Taken | Date of Action | Duration of Trading Arrangement | Aggregate Number of Securities to be Sold |
|---|---|---|---|---|---|
| The Michael Kirban Revocable Trust | A trust controlled by Michael Kirban (Co-Founder and Executive Chairman) | Adoption | December 10, 2025 | March 10, 2026 to March 10, 2027 | Up to 100,000 shares of Common Stock |
| Martin Roper | Chief Executive Officer | Adoption | December 10, 2025 | April 1, 2026 to December 15, 2026 | Up to 250,000 shares of Common Stock subject to a daily maximum of 25,000 shares |
| Jane Morreau | Director | Adoption | November 8, 2025 | February 23, 2026 to November 6, 2026 | Up to 15,000 shares of Common Stock |
| Corey Baker | Chief Financial Officer | Adoption | December 12, 2025 | March 13, 2026 to October 30, 2026 | Up to 10,000 shares of Common Stock, subject to a daily maximum of 2,000 shares |
| Jonathan Burth | Chief Operating Officer | Adoption | December 15, 2025 | March 16, 2026 to January 29, 2027 | Up to 200,000 shares of Common Stock |
| Jane Prior | Chief Marketing Officer | Adoption | December 4, 2025 | March 5, 2026 to August 31, 2026 | Up to 50,000 shares of Common Stock |
| Charles Van Es | Chief Commercial Officer | Adoption | December 15, 2025 | March 16, 2026 to April 30, 2027 | Up to 24,000 shares of Common Stock |
Other than as disclosed above, no other officer, director or entity controlled by such officer or director adopted, modified orterminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.